Abstract: A process for the synthesis of transition metal chalcogenides (TMC) having formula (I). More particularly, the present work relates to a one pot single phase process for the synthesis of a TMC system having formula (I) by wet chemistry. Formula (I) is represented as Ax-By.

Abstract: The present invention relates to an enzymatic process for preparation of optically pure enantiomers of homopropargylic alcohol compounds of formula I, which are useful intermediates for the synthesis of Halichondrin B and analogs. wherein, P is H or an alcohol protecting group, n is an integer ranging from 0-12.

Abstract: Ultrasonic pulse velocity is a parameter for assessing strength of concrete structures and studying elastic properties. A method involves transmission of longitudinal ultrasound by a transmitting transducer and receiving by a similar transducer. A transit time-measurement and associated triggering pulses provide the overall time-measurement resolution of at least 1 ?s. An ultrasonic pulse velocity measuring device capable of generating ultrasound in the solid materials supporting the propagation of ultrasound and precisely measuring the ultrasonic propagation delay time or the transit time is also disclosed. An ultrasonic transit time measurement device having provision for automatic pulse threshold error correction is also disclosed. A method to realize fast counting for generation of high resolution with relatively slower microcontrollers is also disclosed.

Abstract: The present invention provides a symbiotic combination of i) a probiotic micro-organism comprising of a Lactobacillus strain, and ii) a catechin component comprising EGCG that acts as a second generation symbiotic with synergistic effects in improving the immune response and antioxidant capacity during aging that may beneficially affect the health of elderly.

Abstract: The present invention relates to a recombinant microbial system for generation of neo-glycocins, a substrate and to co-evolve its glycosyltransferase enzyme. The recombinant microbial system comprises a gene cassette A encoding for microbial O- and S-glycosyltransferase and its suitable acceptor substrate in conjugation with a cleavable dual affinity tag under the control of two independent inducible promoters. The gene cassette is expressed in a microbial host such as E. coli for the co-expression of glycosyltransferase and its suitable acceptor substrate. The invention further discloses method for production and bioactivity guided screening of O- and or S-neo-glycocins using the recombinant microbial system. The system provides optimized construct design, and methods for high yield production of glycocins and neo-glycocins for downstream applications.

Abstract: The present invention relates to substituted-diazenylanilines of the formula I and their nucleotide conjugates, complexes, salts which may be used potentially as fluorescent quenchers in chemical and biological sciences such as cell imaging applications, diagnostics, fluorescent and non-fluorescent tags, pharmaceuticals and other useful applications, and a process of preparing said new compounds. More particularly, the present invention relates to 2,2?-((4-((2,5-disubstituted-4-((4-nitrophenyl)diazenyl)phenyl)diazenyl)-2/3-substituted-phenyl)azanediyl)dialkanol, processes for preparing said compounds and their use as fluorescent quenchers in cell imaging applications, diagnostics, fluorescent and non-fluorescent tags, pharmaceuticals and other useful applications.

Abstract: The present invention relates to partially bio-based and bio-compatible polyurethane microcapsules. More particularly, the present invention relates to partially bio-based and bio-compatible polyurethane microcapsules for sustained release of an active ingredient. The present invention also relates to a process for the preparation of the partially bio-based and bio-compatible polyurethane microcapsules.

Abstract: The present invention relates to a composition for fuel cell membranes and a process for the preparation thereof. In particular, the present invention relates to thermo-mechanically and chemically stable polymer electrolyte membranes which have been prepared without compromising proton conductivity by using multifunctional polydopamine and mechanically robust nanocellulose.

Abstract: The present invention relates to process for the preparation of cannabidiol (A) from the coupling of (D) and (E) through the intermediates (C) and (D) starting from compound (B). The invention further relates to the novel compounds (B), (C), (D) and (E) and reagents used in this process. More specifically, this invention provides the manufacturing of Cannabidiol (A) in milligram to gram or kilogram scale.

Abstract: Anion-exchange membranes are useful for electro-membrane processes such as electrodialysis (water desalination, separation of inorganics from organic molecules, separation of specific inorganic ion, etc.), in-situ ion-exchange and ion substitution, electro-deionization for producing ultrapure water, polymer electrolyte membrane for alkaline fuel cell and electrolysis applications. The present invention discloses an acid and base resistant fluorinated hydrocarbon based anion-exchange membrane and its method of preparation thereof. In the first step co-polymerization is carried out between N-isopropylacrylamide and 1-vinylimidazole. In the second step, obtained inter-polymer of isopropylacrylamide-co-vinylimidazole co-polymer is mixed with poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-co-HFP) (IA-co-VI/PVDF-co-HFP), which is used for casting membrane film of desired thickness. The obtained casted membrane thin film is quaternized in methyl iodide solution.

Abstract: The present invention deals with development of a novel process for manufacturing moisture resistant glossy finish hybrid green polymeric composites with variable density in range of 0.2-1.68 g/cc, low water/moisture absorption in the range of 0.1-1.3%, tensile strength and tensile modulus in range of 6.5-105 MPa and 250-6850 MPa, respectively and to the best of our knowledge the fabricated hybrid green composites has not yet developed universally using different types of industrial wastes particulates. Moreover, hybrid composites developed using industrial wastes, natural fibres and epoxy/polyester/polyurethane polymers is a unique materials and have multifunctional applications in wider spectrum as an alternative to wood, synthetic wood, wood plastic composites, screen printing sheet, plastic, fibre and glass reinforced polymer products, including tin sheet.

Abstract: The present invention discloses modified forms of plasmin with advantageous properties. As compared to their natural unmodified form, these variants exhibit significantly modulated kinetics in terms of delayed inhibition characteristics in the presence of specific inhibitors, such as ?2-antiplasmin (?2-AP). These include PEG-conjugated thiol derivatives of truncated plasmin with potential clinical applications in various regimens of thrombolytic therapies.

Abstract: The present disclosure relates to a new, simple, two step synthesis of Indolmycin and its derivatives of formula (I), in 4-5 hours. Formula (I) wherein said process comprising the step of: 10 (a) reacting indole derivative with methyl magnesium bromide in a suitable solvent at a temperature in the range of 0-30° C. followed by adding ethyl epoxy butanone in a suitable solvent at ?20° C. for a period of 1-2 hrs and maintaining the obtained reaction mixture for 1 hr at ?20° C. to obtain a compound; and (b) passing the compound obtained at step a), base and N-methylated quinidine 15 through solid-solid continuous flow reactor for 1 minute to obtain the compound of formula (I).

Abstract: The present invention relates to a crystalline, two dimensional polymer of Formula I and a process for the preparation thereof.

Abstract: The present invention relates to the novel formulation for sustained or delayed release of rohitukine-rich Dysoxylum binectariferum extract/fraction and a process for preparing the same wherein the extract is wet-granulated using excipients i.e. biodegradable polymers and/or non-biodegradable polymers alone or in combination, and the said granules are either filled into a capsule or compressed into a tablet. The said formulation comprising a granulated extract/fraction of rohitukine-rich Dysoxylum binectariferum with polymers has resulted in a sustained release of the extract or fraction over a period of 16-24 hrs. The said formulations are useful in the treatment of inflammatory diseases.

Abstract: The present invention provides highly efficient process for the preparation of enantiomerically enriched Sitagliptin of Formula (Ia). More particularly, a direct rhodium catalyzed asymmetric hydrogenation in the presence of bis-phosphine chiral ligand has been developed to yield enantiopure Sitagliptin product with the highest enantiomeric excess of 85-99.9%.

Abstract: The current invention relates to a method for producing an alcohol-free, antimicrobial, moisturising hand sanitizer comprising (i) a polymer-based nanoemulsion including one or more active compounds selected from cyanovirin-N (CV-N), cannabidiol (CBD) and palmitic acid (PA); and (ii) an aqueous gel-like moisturizing composition comprising xanthan gum, glycerol and a preservative such as citric acid. The invention further relates to an alcohol-free, antimicrobial, moisturising hand sanitizer produced by the method of the invention, as well as to use of the hand sanitizer as an antimicrobial, in particular an antiviral agent.

Abstract: The present invention discloses a film comprising porous, amorphous polybenzimidazole (PBI) and at least one filler for use as a separator in a lithium ion battery and a process for preparation thereof.

Abstract: The present invention relates to a process for the preparation of tapentadol and analogs or compounds or stereoisomers of formula (I), Formula I wherein, A is aryl, heteroaryl, and cycloalkyl; R is H, OH, OR1, halogen, C1-C12 alkyl, cycloalkyl, aryl or heteroaryl; R1 is C1-C12 alkyl, cycloalkyl, aryl or heteroaryl, wherein each of these groups may further be substituted with one or more substituent selected from H, OH, halogen, CN, NO2, C1-C4 alkyl or phenyl. Further, the multi-step process involves no column chromatography purification until the very last step. This makes this process highly commercially viable and industrially useful.

Abstract: The invention described herein relates to the compounds of Formula I for treating diseases and disorders for which inhibition or modulation of the topoisomerase I enzyme produces a physiologically beneficial response, in particular for the treatment of breast cancer. Also provided is the process of preparing compounds of Formula I.